{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:43:26Z","timestamp":1784583806072,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Project Program of Nature Science Foundation of Jiangsu Province of China","award":["BK20201329"],"award-info":[{"award-number":["BK20201329"]}]},{"name":"the Project Program of National Nature Science Foundation of China","award":["81872757"],"award-info":[{"award-number":["81872757"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["No. 2632018ZD01"],"award-info":[{"award-number":["No. 2632018ZD01"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["No. 2632020ZD10"],"award-info":[{"award-number":["No. 2632020ZD10"]}]},{"name":"Innovation and Entrepreneurship Training Program for Undergraduate","award":["No. 201910316220"],"award-info":[{"award-number":["No. 201910316220"]}]},{"name":"Innovation and Entrepreneurship Training Program for Undergraduate","award":["No. 202010316245)"],"award-info":[{"award-number":["No. 202010316245)"]}]},{"name":"the Medical Science and Technology Research Project of Henan Province","award":["no. SBGJ202003010"],"award-info":[{"award-number":["no. SBGJ202003010"]}]},{"name":"the Science and Technology Research Project of Henan Province","award":["no. 202102310158"],"award-info":[{"award-number":["no. 202102310158"]}]},{"name":"the Project Program of the Project Program of National Nature Science Foundation of China","award":["82173842"],"award-info":[{"award-number":["82173842"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00018-022-04384-1","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T16:11:44Z","timestamp":1654963904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis"],"prefix":"10.1007","volume":"79","author":[{"given":"Yue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuolu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2183-4974","authenticated-orcid":false,"given":"Lufeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"issue":"1","key":"4384_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40169-018-0205-6","volume":"7","author":"W Chen","year":"2018","unstructured":"Chen W, Qin Y, Liu S (2018) Cytokines, breast cancer stem cells (BCSCs) and chemoresistance. Clin Transl Med 7(1):27","journal-title":"Clin Transl Med"},{"key":"4384_CR2","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3389\/fonc.2020.01334","volume":"10","author":"S Fiorentino","year":"2020","unstructured":"Fiorentino S, Urue\u00f1a C, Lasso P, Prieto K, Barreto A (2020) Phyto-immunotherapy, a complementary therapeutic option to decrease metastasis and attack breast cancer stem cells. Front Oncol 10:1334","journal-title":"Front Oncol"},{"key":"4384_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","volume":"44","author":"C Peitzsch","year":"2017","unstructured":"Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A (2017) Cancer stem cells: the root of tumor recurrence and metastases. Semin Cancer Biol 44:10\u201324","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"4384_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00018-016-2334-7","volume":"74","author":"F Yang","year":"2017","unstructured":"Yang F, Xu J, Tang L, Guan X (2017) Breast cancer stem cell: the roles and therapeutic implications. Cell Mol Life Sci 74(6):951\u2013966","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4384_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13045-020-00901-6","volume":"13","author":"Y Yang","year":"2020","unstructured":"Yang Y, Li X, Wang T, Guo Q, Xi T, Zheng L (2020) Emerging agents that target signaling pathways in cancer stem cells. J Hematol Oncol 13(1):60","journal-title":"J Hematol Oncol"},{"issue":"20","key":"4384_CR6","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1158\/1078-0432.CCR-19-0365","volume":"25","author":"KJ Norsworthy","year":"2019","unstructured":"Norsworthy KJ, By K, Subramaniam S, Zhuang L, Del Valle PL, Przepiorka D, Shen YL, Sheth CM, Liu C, Leong R et al (2019) FDA approval summary: Glasdegib for newly diagnosed acute myeloid Leukemia. Clin Cancer Res 25(20):6021\u20136025","journal-title":"Clin Cancer Res"},{"key":"4384_CR7","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.2147\/OTT.S228342","volume":"13","author":"G Beziat","year":"2020","unstructured":"Beziat G, Ysebaert L (2020) Tagraxofusp for the treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): a brief report on emerging data. Onco Targets Ther 13:5199\u20135205","journal-title":"Onco Targets Ther"},{"issue":"1","key":"4384_CR8","doi-asserted-by":"publisher","first-page":"17667","DOI":"10.1038\/s41598-017-17804-1","volume":"7","author":"C Raggi","year":"2017","unstructured":"Raggi C, Gammella E, Correnti M, Buratti P, Forti E, Andersen JB, Alpini G, Glaser S, Alvaro D, Invernizzi P et al (2017) Dysregulation of iron metabolism in Cholangiocarcinoma stem-like cells. Sci Rep 7(1):17667","journal-title":"Sci Rep"},{"issue":"4","key":"4384_CR9","first-page":"25","volume":"62","author":"U Ozer","year":"2016","unstructured":"Ozer U (2016) The role of Iron on breast cancer stem-like cells. Cell Mol Biol (Noisy-le-grand) 62(4):25\u201330","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"29","key":"4384_CR10","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1038\/onc.2017.11","volume":"36","author":"D Basuli","year":"2017","unstructured":"Basuli D, Tesfay L, Deng Z, Paul B, Yamamoto Y, Ning G, Xian W, McKeon F, Lynch M, Crum CP et al (2017) Iron addiction: a novel therapeutic target in ovarian cancer. Oncogene 36(29):4089\u20134099","journal-title":"Oncogene"},{"key":"4384_CR11","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.2147\/CMAR.S204852","volume":"11","author":"K Bajbouj","year":"2019","unstructured":"Bajbouj K, Shafarin J, Hamad M (2019) Estrogen-dependent disruption of intracellular iron metabolism augments the cytotoxic effects of doxorubicin in select breast and ovarian cancer cells. Cancer Manage Res 11:4655\u20134668","journal-title":"Cancer Manage Res"},{"issue":"7","key":"4384_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.208","volume":"7","author":"S Ma","year":"2016","unstructured":"Ma S, Henson ES, Chen Y, Gibson SB (2016) Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis 7(7):e2307","journal-title":"Cell Death Dis"},{"issue":"1","key":"4384_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12885-019-5642-0","volume":"19","author":"VC Chang","year":"2019","unstructured":"Chang VC, Cotterchio M, Khoo E (2019) Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis. BMC Cancer 19(1):543","journal-title":"BMC Cancer"},{"issue":"8","key":"4384_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182921","volume":"12","author":"S Ma","year":"2017","unstructured":"Ma S, Dielschneider RF, Henson ES, Xiao W, Gibson SB (2017) Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells. PLoS\u00a0One 12(8):e0182921","journal-title":"PLoS\u00a0One"},{"issue":"5","key":"4384_CR15","doi-asserted-by":"publisher","first-page":"mfab021","DOI":"10.1093\/mtomcs\/mfab021","volume":"13","author":"M Plays","year":"2021","unstructured":"Plays M, M\u00fcller S, Rodriguez R (2021) Chemistry and biology of ferritin. Metallomics 13(5):mfab021","journal-title":"Metallomics"},{"issue":"6","key":"4384_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1042\/BJ20150658","volume":"473","author":"S Torii","year":"2016","unstructured":"Torii S, Shintoku R, Kubota C, Yaegashi M, Torii R, Sasaki M, Suzuki T, Mori M, Yoshimoto Y, Takeuchi T et al (2016) An essential role for functional lysosomes in ferroptosis of cancer cells. Biochem J 473(6):769\u2013777","journal-title":"Biochem J"},{"issue":"10","key":"4384_CR17","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nchem.2778","volume":"9","author":"TT Mai","year":"2017","unstructured":"Mai TT, Hamai A, Hienzsch A, Caneque T, Muller S, Wicinski J, Cabaud O, Leroy C, David A, Acevedo V et al (2017) Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat Chem 9(10):1025\u20131033","journal-title":"Nat Chem"},{"issue":"24","key":"4384_CR18","doi-asserted-by":"publisher","first-page":"15532","DOI":"10.1021\/acs.analchem.9b03438","volume":"91","author":"M Corte-Rodr\u00edguez","year":"2019","unstructured":"Corte-Rodr\u00edguez M, Blanco-Gonz\u00e1lez E, Bettmer J, Montes-Bay\u00f3n M (2019) Quantitative analysis of transferrin receptor 1 (TfR1) in individual breast cancer cells by means of labeled antibodies and elemental (ICP-MS) detection. Anal Chem 91(24):15532\u201315538","journal-title":"Anal Chem"},{"issue":"2","key":"4384_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/tox.23031","volume":"36","author":"Y Xu","year":"2021","unstructured":"Xu Y, Wang Q, Li X, Chen Y, Xu G (2021) Itraconazole attenuates the stemness of nasopharyngeal carcinoma cells via triggering ferroptosis. Environ Toxicol 36(2):257\u2013266","journal-title":"Environ Toxicol"},{"issue":"4","key":"4384_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/tox.23057","volume":"36","author":"J Sun","year":"2020","unstructured":"Sun J, Cheng X, Pan S, Wang L, Dou W, Liu J, Shi X (2020) Dichloroacetate attenuates the stemness of colorectal cancer cells via trigerring ferroptosis through sequestering iron in lysosomes. Environ Toxicol 36(4):520\u2013529","journal-title":"Environ Toxicol"},{"issue":"21","key":"4384_CR21","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.1158\/0008-5472.CAN-11-1870","volume":"71","author":"LD Miller","year":"2011","unstructured":"Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D\u2019Agostino R Jr, Torti SV, Torti FM (2011) An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res 71(21):6728\u20136737","journal-title":"Cancer Res"},{"issue":"10","key":"4384_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","volume":"12","author":"S M\u00fcller","year":"2020","unstructured":"M\u00fcller S, Sindikubwabo F, Ca\u00f1eque T, Lafon A, Versini A, Lombard B, Loew D, Wu TD, Ginestier C, Charafe-Jauffret E et al (2020) CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat Chem 12(10):929\u2013938","journal-title":"Nat Chem"},{"issue":"8","key":"4384_CR23","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/tox.23161","volume":"36","author":"K Wang","year":"2021","unstructured":"Wang K, Chen X, Zuyi W, Chen L, Fu W (2021) Lysosome Fe(2+) release is responsible for etoposide- and cisplatin-induced stemness of small cell lung cancer cells. Environ Toxicol 36(8):1654\u20131663","journal-title":"Environ Toxicol"},{"issue":"1","key":"4384_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13046-018-0733-3","volume":"37","author":"B Zhao","year":"2018","unstructured":"Zhao B, Li X, Wang Y, Shang P (2018) Iron-dependent cell death as executioner of cancer stem cells. J Exp Clin Cancer Res 37(1):79","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"4384_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182921","volume":"12","author":"S Ma","year":"2017","unstructured":"Ma S, Dielschneider RF, Henson ES, Xiao W, Choquette TR, Blankstein AR, Chen Y, Gibson SB (2017) Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells. PLoS\u00a0One 12(8):e0182921","journal-title":"PLoS\u00a0One"},{"issue":"4","key":"4384_CR26","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.celrep.2019.03.079","volume":"27","author":"EE Mulkearns-Hubert","year":"2019","unstructured":"Mulkearns-Hubert EE, Torre-Healy LA, Silver DJ, Eurich JT, Bayik D, Serbinowski E, Hitomi M, Zhou J, Przychodzen B, Zhang R et al (2019) Development of a Cx46 targeting strategy for cancer stem cells. Cell Rep 27(4):1062\u20131072 (e1065)","journal-title":"Cell Rep"},{"issue":"4","key":"4384_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3324\/haematol.2018.194910","volume":"105","author":"H Kumar","year":"2020","unstructured":"Kumar H, Chattopadhyay S, Das N, Shree S, Patel D, Mohapatra J, Gurjar A, Kushwaha S, Singh AK, Dubey S et al (2020) Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-\u03b3 and synergizes with imatinib to inhibit chronic myeloid leukemia cells. Haematologica 105(4):971\u2013986","journal-title":"Haematologica"},{"key":"4384_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.leukres.2017.01.019","volume":"55","author":"\u0130Z Durusu","year":"2017","unstructured":"Durusu \u0130Z, H\u00fcsn\u00fcgil HH, Ata\u015f H, Biber A, Gerek\u00e7i S, G\u00fcle\u00e7 EA, \u00d6zen C (2017) Anti-cancer effect of clofazimine as a single agent and in combination with cisplatin on U266 multiple myeloma cell line. Leuk Res 55:33\u201340","journal-title":"Leuk Res"},{"key":"4384_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.canlet.2019.02.018","volume":"449","author":"K Ahmed","year":"2019","unstructured":"Ahmed K, Koval A, Xu J, Bodmer A, Katanaev VL (2019) Towards the first targeted therapy for triple-negative breast cancer: repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor. Cancer Lett 449:45\u201355","journal-title":"Cancer Lett"},{"key":"4384_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejmech.2017.04.040","volume":"135","author":"Y Lu","year":"2017","unstructured":"Lu Y, Wang L, Xiaobing X, Tao L, Jianmin Z (2017) Design, combinatorial synthesis and biological evaluations of novel 3-amino-1\u2032-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2\u2032-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3\u2032-indoline]-2-carbonitrile antitumor hybrid molecules. Eur J Med Chem 135:125\u2013141","journal-title":"Eur J Med Chem"},{"issue":"1","key":"4384_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1386207322666190307125015","volume":"22","author":"Z Mei-Chen","year":"2019","unstructured":"Mei-Chen Z, Shu-Hui G, Guang-Pan L, Chen-Cheng L, Han-Mei X (2019) Facile synthesis and cytotoxicity of phenazine-chromene hybrid molecules derived from phenazine natural product. Combin Chem High Throughput Screen 22(1):35\u201340","journal-title":"Combin Chem High Throughput Screen"},{"key":"4384_CR32","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ejmech.2016.10.068","volume":"127","author":"Y Lu","year":"2016","unstructured":"Lu Y, Yan Y, Wang L, Wang X, Gao J, Xi T, Wang Z, Jiang F (2016) Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents. Eur J Med Chem 127:928\u2013943","journal-title":"Eur J Med Chem"},{"issue":"10","key":"4384_CR33","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2174\/1386207318666150915113549","volume":"18","author":"J Gao","year":"2015","unstructured":"Gao J, Chen M, Tong X, Zhu H, Yan H, Liu D, Li W, Qi S, Xiao D, Wang Y (2015) Synthesis, antitumor activity, and structure-activity relationship of some benzo[a]pyrano[2,3-c]phenazine derivatives. Combin Chem High Throughput Screen 18(10):960\u2013974","journal-title":"Combin Chem High Throughput Screen"},{"key":"4384_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109459","volume":"120","author":"S Ghafouri-Fard","year":"2019","unstructured":"Ghafouri-Fard S, Taheri M (2019) UCA1 long non-coding RNA: an update on its roles in malignant behavior of cancers. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 120:109459","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"4","key":"4384_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/ncrna4040040","volume":"4","author":"CM Klinge","year":"2018","unstructured":"Klinge CM (2018) Non-coding RNAs in breast cancer: intracellular and intercellular communication. Non-coding RNA 4(4):40","journal-title":"Non-coding RNA"},{"issue":"2","key":"4384_CR36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, Jiang X (2019) Role of Mitochondria in Ferroptosis. Mol Cell 73(2):354-363.e353","journal-title":"Mol Cell"},{"issue":"3","key":"4384_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5483\/BMBRep.2017.50.3.222","volume":"50","author":"K Eun","year":"2017","unstructured":"Eun K, Ham SW, Kim H (2017) Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting. BMB Rep 50(3):117\u2013125","journal-title":"BMB Rep"},{"issue":"42","key":"4384_CR38","doi-asserted-by":"publisher","first-page":"44191","DOI":"10.18632\/oncotarget.6176","volume":"6","author":"T Wang","year":"2015","unstructured":"Wang T, Shigdar S, Gantier MP, Hou Y, Wang L, Li Y, Shamaileh HA, Yin W, Zhou SF, Zhao X et al (2015) Cancer stem cell targeted therapy: progress amid controversies. Oncotarget 6(42):44191\u201344206","journal-title":"Oncotarget"},{"issue":"7","key":"4384_CR39","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2217\/bmm-2017-0398","volume":"12","author":"CJ O'Conor","year":"2018","unstructured":"O\u2019Conor CJ, Chen T, Gonz\u00e1lez I, Cao D, Peng Y (2018) Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker. Biomark Med 12(7):813\u2013820","journal-title":"Biomark Med"},{"issue":"11","key":"4384_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nnano.2016.164","volume":"11","author":"SE Kim","year":"2016","unstructured":"Kim SE, Zhang L, Ma K, Riegman M, Chen F, Ingold I, Conrad M, Turker MZ, Gao M, Jiang X et al (2016) Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat Nanotechnol 11(11):977\u2013985","journal-title":"Nat Nanotechnol"},{"issue":"33","key":"4384_CR41","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1002\/chem.202000335","volume":"26","author":"A Versini","year":"2020","unstructured":"Versini A, Colombeau L, Hienzsch A, Gaillet C, Retailleau P, Debieu S, Muller S, Caneque T, Rodriguez R (2020) Salinomycin derivatives kill breast cancer stem cells via Lysosomal iron targeting. Chemistry 26(33):7416\u20137424","journal-title":"Chemistry"},{"issue":"14","key":"4384_CR42","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1002\/anie.201913712","volume":"59","author":"L Laraia","year":"2020","unstructured":"Laraia L, Garivet G, Foley DJ, Kaiser N, M\u00fcller S, Zinken S, Pinkert T, Wilke J, Corkery D, Pahl A et al (2020) Image-based morphological profiling identifies a Lysosomotropic, iron-sequestering autophagy inhibitor. Angew Chem Int Ed Engl 59(14):5721\u20135729","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"4384_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00418-008-0394-y","volume":"129","author":"T Kurz","year":"2008","unstructured":"Kurz T, Terman A, Gustafsson B, Brunk UT (2008) Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol 129(4):389\u2013406","journal-title":"Histochem Cell Biol"},{"issue":"13","key":"4384_CR44","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1158\/0008-5472.CAN-20-2936","volume":"81","author":"J Goncalves","year":"2021","unstructured":"Goncalves J, Moog S, Morin A, Gentric G, M\u00fcller S, Morrell AP, Kluckova K, Stewart TJ, Andoniadou CL, Lussey-Lepoutre C et al (2021) Loss of SDHB promotes dysregulated iron homeostasis, oxidative stress, and sensitivity to ascorbate. Cancer Res 81(13):3480\u20133494","journal-title":"Cancer Res"},{"issue":"19","key":"4384_CR45","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1158\/0008-5472.CAN-15-0798","volume":"75","author":"K Rycaj","year":"2015","unstructured":"Rycaj K, Tang DG (2015) Cell-of-origin of cancer versus cancer stem cells: assays and interpretations. Cancer Res 75(19):4003\u20134011","journal-title":"Cancer Res"},{"issue":"4","key":"4384_CR46","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","volume":"172","author":"S Su","year":"2018","unstructured":"Su S, Chen J, Yao H, Liu J, Yu S, Lao L, Wang M, Luo M, Xing Y, Chen F et al (2018) CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell 172(4):841-856.e816","journal-title":"Cell"},{"issue":"4","key":"4384_CR47","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ccell.2015.09.002","volume":"28","author":"DL Schonberg","year":"2015","unstructured":"Schonberg DL, Miller TE, Wu Q, Flavahan WA, Das NK, Hale JS, Hubert CG, Mack SC, Jarrar AM, Karl RT et al (2015) Preferential iron trafficking characterizes glioblastoma stem-like cells. Cancer Cell 28(4):441\u2013455","journal-title":"Cancer Cell"},{"key":"4384_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/272940","volume":"2010","author":"R Raghupathy","year":"2010","unstructured":"Raghupathy R, Manwani D, Little JA (2010) Iron overload in sickle cell disease. Adv Hematol 2010:272940","journal-title":"Adv Hematol"},{"issue":"Suppl 1","key":"4384_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/liv.13020","volume":"36","author":"A Pietrangelo","year":"2016","unstructured":"Pietrangelo A (2016) Iron and the liver. Liver Int 36(Suppl 1):116\u2013123","journal-title":"Liver Int"},{"issue":"20","key":"4384_CR50","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","volume":"124","author":"DT Kremastinos","year":"2011","unstructured":"Kremastinos DT, Farmakis D (2011) Iron overload cardiomyopathy in clinical practice. Circulation 124(20):2253\u20132263","journal-title":"Circulation"},{"key":"4384_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.731741","volume":"12","author":"W Zhao","year":"2021","unstructured":"Zhao W, Liu J, Li Y, Chen Z, Qi D, Zhang Z (2021) Immune effect of active components of traditional Chinese medicine on triple-negative breast cancer. Front Pharmacol 12:731741","journal-title":"Front Pharmacol"},{"issue":"14","key":"4384_CR52","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100852","volume":"38","author":"P Tharmapalan","year":"2019","unstructured":"Tharmapalan P, Mahendralingam M, Berman HK, Khokha R (2019) Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention. EMBO J 38(14):e100852","journal-title":"EMBO J"},{"key":"4384_CR53","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.omtn.2020.06.018","volume":"21","author":"Q Guo","year":"2020","unstructured":"Guo Q, Wang T, Yang Y, Gao L, Zhao Q, Zhang W, Xi T, Zheng L (2020) Transcriptional Factor Yin Yang 1 promotes the stemness of breast cancer cells by suppressing miR-873-5p transcriptional activity. Mol Ther Nucleic acids 21:527\u2013541","journal-title":"Mol Ther Nucleic acids"},{"issue":"9","key":"4384_CR54","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1021\/acs.jmedchem.7b01903","volume":"61","author":"AT Garrison","year":"2018","unstructured":"Garrison AT, Abouelhassan Y, Kallifidas D, Tan H, Kim YS, Jin S, Luesch H, Huigens RW 3rd (2018) An efficient buchwald-hartwig\/reductive cyclization for the scaffold diversification of halogenated phenazines: potent antibacterial targeting, biofilm eradication, and prodrug exploration. J Med Chem 61(9):3962\u20133983","journal-title":"J Med Chem"},{"issue":"11","key":"4384_CR55","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1021\/acs.jmedchem.1c00168","volume":"64","author":"H Yang","year":"2021","unstructured":"Yang H, Kundra S, Chojnacki M, Liu K, Fuse MA, Abouelhassan Y, Kallifidas D, Zhang P, Huang G, Jin S et al (2021) A modular synthetic route involving N-aryl-2-nitrosoaniline intermediates leads to a new series of 3-substituted halogenated phenazine antibacterial agents. J Med Chem 64(11):7275\u20137295","journal-title":"J Med Chem"},{"issue":"17","key":"4384_CR56","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1016\/j.febslet.2014.07.003","volume":"588","author":"J Yang","year":"2014","unstructured":"Yang J, Li T, Gao C, Lv X, Liu K, Song H, Xing Y, Xi T (2014) FOXO1 3\u2019UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity. FEBS Lett 588(17):3218\u20133224","journal-title":"FEBS Lett"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04384-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04384-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04384-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T02:06:42Z","timestamp":1666577202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04384-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4384"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04384-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"5 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the experiments were obtained the approval of the Ethics Committee for Animal Experimentation of China Pharmaceutical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"360"}}